Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lien Lippens

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The EMBO Journal|December 11, 2023
Extracellular vesicles and co-isolated endogenous retroviruses from murine cancer cells differentially affect dendritic cellsFederico Cocozza, Lorena Martin-Jaular, Lien Lippens, et al.
Gut|December 7, 2018
Increased levels of systemic LPS-positive bacterial extracellular vesicles in patients with intestinal barrier dysfunctionJoeri Tulkens, Glenn Vergauwen, Jan Van Deun, et al.
Gynecologic Oncology|August 30, 2020
Splenic <sup>18</sup>F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancerEmiel A De Jaeghere, Frederiek Laloo, Lien Lippens, et al.
Gynecologic Oncology|November 8, 2024
Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO trialEmiel A De Jaeghere, Hannelore Hamerlinck, Sandra Tuyaerts, et al.
Cancer Immunology, Immunotherapy : CII|December 31, 2024
Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO studyEmiel A De Jaeghere, Sandra Tuyaerts, An M T Van Nufel, et al.
Cancer Immunology, Immunotherapy : CII|August 12, 2022
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO studyEmiel A De Jaeghere, Sandra Tuyaerts, An M T Van Nuffel, et al.
Nature Communications|July 25, 2019
The generation and use of recombinant extracellular vesicles as biological reference materialEdward Geeurickx, Joeri Tulkens, Bert Dhondt, et al.
Journal of Extracellular Biology|February 26, 2024
International Society for Extracellular Vesicles Workshop. QuantitatEVs: multiscale analyses, from bulk to single extracellular vesicleManuela Basso, Alessandro Gori, Caterina Nardella, et al.
Nature Methods|March 1, 2017
EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research, Jan Van Deun, Pieter Mestdagh, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The EMBO Journal|December 11, 2023
Extracellular vesicles and co-isolated endogenous retroviruses from murine cancer cells differentially affect dendritic cellsFederico Cocozza, Lorena Martin-Jaular, Lien Lippens, et al.
Gut|December 7, 2018
Increased levels of systemic LPS-positive bacterial extracellular vesicles in patients with intestinal barrier dysfunctionJoeri Tulkens, Glenn Vergauwen, Jan Van Deun, et al.
Gynecologic Oncology|August 30, 2020
Splenic <sup>18</sup>F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancerEmiel A De Jaeghere, Frederiek Laloo, Lien Lippens, et al.
Gynecologic Oncology|November 8, 2024
Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO trialEmiel A De Jaeghere, Hannelore Hamerlinck, Sandra Tuyaerts, et al.
Cancer Immunology, Immunotherapy : CII|December 31, 2024
Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO studyEmiel A De Jaeghere, Sandra Tuyaerts, An M T Van Nufel, et al.
Cancer Immunology, Immunotherapy : CII|August 12, 2022
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO studyEmiel A De Jaeghere, Sandra Tuyaerts, An M T Van Nuffel, et al.
Nature Communications|July 25, 2019
The generation and use of recombinant extracellular vesicles as biological reference materialEdward Geeurickx, Joeri Tulkens, Bert Dhondt, et al.
Journal of Extracellular Biology|February 26, 2024
International Society for Extracellular Vesicles Workshop. QuantitatEVs: multiscale analyses, from bulk to single extracellular vesicleManuela Basso, Alessandro Gori, Caterina Nardella, et al.
Nature Methods|March 1, 2017
EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research, Jan Van Deun, Pieter Mestdagh, et al.
Pageof 2